Showing results (1-10 of 83) with videos related to
Sort By:
Pageof 9
European Journal of Cell Biology|August 19, 2008
Pathophysiological roles of osteoprotegerin (OPG)Penny Reid, Ingunn HolenJournal of Bone Oncology|February 25, 2016
The role of macrophages in bone metastasisIfigenia Vasiliadou, Ingunn HolenRecent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|February 7, 2012
Combinations of bisphosphonates and classical anticancer drugs: a preclinical perspectiveMaria Michailidou, Ingunn HolenJournal of Translational Medicine|October 19, 2011
Tumour macrophages as potential targets of bisphosphonatesThea L Rogers, Ingunn HolenBreast Cancer Research : BCR|December 24, 2010
Anti-tumour activity of bisphosphonates in preclinical models of breast cancerIngunn Holen, Robert E ColemanClinical Science (London, England : 1979)|February 9, 2006
Role of osteoprotegerin (OPG) in cancerIngunn Holen, Claire M ShipmanCurrent Pharmaceutical Design|February 20, 2010
Bisphosphonates as treatment of bone metastasesIngunn Holen, Robert E ColemanEndocrine-Related Cancer|October 1, 2016
The endocrine influence on the bone microenvironment in early breast cancerCaroline Wilson, Hannah Brown, Ingunn HolenMedcomm|January 3, 2022
CDK4/6 inhibitors: A potential therapeutic approach for triple negative breast cancerLubaid Saleh, Caroline Wilson, Ingunn HolenActa Oncologica (Stockholm, Sweden)|November 1, 2019
CDK4/6 inhibitors in breast cancer - from <i>in vitro</i> models to clinical trialsLubaid Saleh, Caroline Wilson, Ingunn HolenPageof 9